Dr. Lal PathLabs Reports Strong Q2 FY27 Results and Declares Interim Dividend
Dr. Lal PathLabs Ltd 路 Dividend 路 04 Nov 2026, 7:05 pm
Dr. Lal PathLabs Reports Strong Q2 FY27 Results and Declares Interim Dividend Dr. Lal PathLabs reported consolidated revenue of INR 8,739 Mn for the quarter ended 30th Sep'26, up 19.6% YoY and 9.6% QoQ. Consolidated net profit rose 27.4% YoY and 13.7% QoQ to INR 1,939 Mn. Basic EPS stood at INR 11.51 versus INR 9.03 in the year-ago period. The board declared a second interim dividend of INR 5 per share (50% on face value of INR 10) with a record date of 11th Nov'26, and approved investing up to INR 49.5 Cr in wholly owned subsidiary LPL Dubai.
Original exchange filing (PDF)
More announcements from Dr. Lal PathLabs Ltd
- Attached 路 11 Nov 2026
- Attached 路 10 Nov 2026
- Attached 路 05 Nov 2026
- Attached 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Attached 路 04 Nov 2026
- Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
- Attached 路 04 Nov 2026
